Collectively, our results confirm ERRα as a master regulator of oncometabolic and proliferating signals in breast cancer, and provide insights into the molecular mechanisms underpinning VDR genomic and antitumor action in advanced breast cancer. Here, ESRRA is linked to breast cancer.